Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
Open Access
- 1 November 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (11) , 2013-2020
Abstract
We performed a multi-centre randomized controlled trial to compare the efficacy of mycophenolate mofetil (MMF) to that of cyclosporine A (CsA) in treating children with frequently relapsing nephrotic syndrome and biopsy-proven minimal change disease. Of the 31 randomized initially selected patients, seven were excluded. The remaining 24 children received either MMF 1200 mg/m2 per day (n = 12) or CsA 4–5 mg/kg per day (n = 12) during a 12-month period. Of the 12 patients in the MMF group, two discontinued the study medication. Evaluation of the changes from the baseline glomerular filtration rate showed an overall significant difference in favour of MMF over the treatment period (p = 0.03). Seven of the 12 patients in the MMF group and 11 of the 12 patients in the CsA group remained in complete remission during the entire study period. Relapse rate in the MMF group was 0.83/year compared to 0.08/year in the CsA group (p = 0.08). None of the patients reported diarrhea. Pharmacokinetic profiles of mycophenolic acid were performed in seven patients. The patient with the lowest area under the curve had three relapses within 6 months. In children with frequently relapsing minimal change nephrotic syndrome, MMF has a favourable side effect profile compared to CsA; however, there is a tendency towards a higher relapse risk in patients treated with MMF.Keywords
This publication has 39 references indexed in Scilit:
- Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndromePediatric Nephrology, 2007
- A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndromePediatric Nephrology, 2006
- Estimation of the glomerular filtration rate in children: which algorithm should be used?Pediatric Nephrology, 2005
- Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndromePediatric Nephrology, 2005
- Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndromePediatric Nephrology, 2005
- Switch from cyclosporine A to mycophenolate mofetil in nephrotic childrenPediatric Nephrology, 2005
- Mycophenolate mofetil in children with multidrug-resistant nephrotic syndromeClinical Nephrology, 2004
- Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndromePediatric Nephrology, 2003
- Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockadePediatric Nephrology, 2003
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996